Global Filters




Tiers


Species


Attribution

Filter by Tier
Filter by Species
Filter by Attributions
like "mouse, Ap3m2, alcohol"

Returning 849 results: Page 1 of 34


Tier Species Size Attr. GeneSet
Tier I 10720 GS125506: Valproic Acid interacting with Homo sapiens associated genes (MeSH:D014635) in CTD
Tier I 4560 GS125634: trichostatin A interacting with Homo sapiens associated genes (MeSH:C012589) in CTD
Tier IV 18653 GS407376: Dysregulation of NRSF/REST via EHMT1 is associated with psychiatric disorders and Kleefstra syndrome
Tier III 19901 GS407933: Differentially expressed genes of post mortem human central Amygdala samples in patients affected by opioid use disorder (OUD) vs. unaffected control samples_Log2FC
Tier III 19901 GS407934: Differentially expressed genes of post mortem human central Amygdala samples in patients affected by opioid use disorder (OUD) vs. unaffected control samples_qvalue
Tier III 19111 GS407935: Differentially expressed genes in human kidney tumors associated with extended opioid exposure_logFC
Tier III 19111 GS407936: Differentially expressed genes in human kidney tumors associated with extended opioid exposure_FDR
Tier III 1918 GS407940: Differentially expressed genes of ventral midbrain in humans with chronic opioid use disorder in microglia
Tier III 17086 GS407944: Differentially expressed genes in opioid use disorder postmortem human brain_qvalue
Tier III 17086 GS407945: Differentially expressed genes in opioid use disorder postmortem human brain_log2FC
Tier III 18513 GS407948: Differentially expressed genes in humans nucleus accumbens associated with opioid use disorder_log2FC
Tier III 18278 GS407950: Differentially expressed genes in humans dorsolateral prefrontal cortex associated with opioid use disorder_log2FC
Tier III 18278 GS407951: Differentially expressed genes in humans dorsolateral prefrontal cortex associated with opioid use disorder_qvalue
Tier III 19863 GS407964: Differential gene expression in human postmortem tissue samples of the dorsolateral prefrontal cortex_logFC
Tier III 19863 GS407965: Differential gene expression in human postmortem tissue samples of the dorsolateral prefrontal cortex_qvalue
Tier IV 10391 GS408184: Differential gene expression comparison between Carnegie Stages (CS) 13 and 22 during human embryo craniofacial development, log2FC
Tier IV 10391 GS408185: Differential gene expression comparison between Carnegie Stages (CS) 13 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 10134 GS408189: Differential gene expression comparison between Carnegie Stages (CS) 14 and 22 during human embryo craniofacial development, log2FC
Tier IV 10134 GS408190: Differential gene expression comparison between Carnegie Stages (CS) 14 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 13854 GS408212: Transcriptional differences in dorsolateral prefrontal cortex (DLPFC) and nucleus accumbens (NAc) in unaffected comparison subjects_coefficient
Tier IV 13854 GS408213: Transcriptional differences in dorsolateral prefrontal cortex (DLPFC) and nucleus accumbens (NAc) in unaffected comparison subjects_qvalue
Tier IV 13854 GS408215: Transcriptional differences in dorsolateral prefrontal cortex (DLPFC) in human opioid use disorder subjects_coefficient
Tier IV 13854 GS408217: Transcriptional differences in nucleus accumbens (NAc) in human opioid use disorder subjects_coefficient
Tier IV 169 GS408222: Differential gene expression associated with opioids in humans_dorsolateral prefrontal cortex_reanalysis of Corradin et al. 2022_log2FC
Tier IV 169 GS408223: Differential gene expression associated with opioids in humans_dorsolateral prefrontal cortex_reanalysis of Corradin et al. 2022_qvalue